HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double blind controlled trial of Bencard house dust mite (Migen) hyposensitisation in Zambian asthmatics.

Abstract
A double blind controlled trial of Bencard HDM (Migen) for the prophylaxis of asthma in a group of Zambian asthmatics failed to show any benefit. The trial results suggest that asthmatics can benefit from regular supervision and the position of prophylactic and therapeutic medication.
AuthorsD J Buchanan, A Hillis, P N Williams
JournalMedical journal of Zambia (Med J Zambia) 1980 Dec-1981 Jan Vol. 15 Issue 1 Pg. 14-6 ISSN: 0047-651X [Print] Zambia
PMID6821012 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Aldehydes
  • Allergens
  • Antigens
  • Antigens, Dermatophagoides
  • Antigens, Plant
  • Drug Combinations
  • Dust
  • Plant Extracts
  • migen
  • Tyrosine
  • Parietaria judaica pollen
  • Glutaral
Topics
  • Adult
  • Aldehydes (therapeutic use)
  • Allergens (therapeutic use)
  • Antigens (therapeutic use)
  • Antigens, Dermatophagoides
  • Antigens, Plant (therapeutic use)
  • Asthma (immunology, prevention & control)
  • Clinical Trials as Topic
  • Desensitization, Immunologic
  • Double-Blind Method
  • Drug Combinations (therapeutic use)
  • Dust
  • Female
  • Glutaral (therapeutic use)
  • Humans
  • Immunotherapy
  • Male
  • Middle Aged
  • Mites (immunology)
  • Phytotherapy
  • Plant Extracts
  • Pollen (therapeutic use)
  • Random Allocation
  • Tyrosine (therapeutic use)
  • Zambia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: